<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-17T21:03:01+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2710】「2020金研奖」血液系统肿瘤单元入围名单揭晓</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/J8PU02wJ5ohxJHhqerFM-A</id>
    <link href="https://mp.weixin.qq.com/s/J8PU02wJ5ohxJHhqerFM-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>WCLC20 前瞻丨来看看免疫治疗更多的长期生存数据</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/akrihgYPBK7JOShvV7Om4Q</id>
    <link href="https://mp.weixin.qq.com/s/akrihgYPBK7JOShvV7Om4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2021 ASCO-GI】信迪利单抗联合CapeOx方案胃癌新辅助数据惊艳，或可成为局晚期胃癌术前治疗新选择</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/_cQlwPyBEskKiZejK449JQ</id>
    <link href="https://mp.weixin.qq.com/s/_cQlwPyBEskKiZejK449JQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MET异常是ALK阳性肺癌中不可忽视的耐药机制（下）</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/uw1iE_LBAP3BvsnsFVMjXA</id>
    <link href="https://mp.weixin.qq.com/s/uw1iE_LBAP3BvsnsFVMjXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离就是战斗，有问必有所得” | 【5】绝经还是未绝经，这是个问题！</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/lAOKiB5to9ljjZoKlihETQ</id>
    <link href="https://mp.weixin.qq.com/s/lAOKiB5to9ljjZoKlihETQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>淋巴结肿大怎么办？会癌变吗？（上篇）</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/_HKTk4o3a6uGZRiM0OI9Jg</id>
    <link href="https://mp.weixin.qq.com/s/_HKTk4o3a6uGZRiM0OI9Jg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>淋巴结肿大怎么办？会癌变吗？（下篇）</title>
    <updated>2021-01-17T19:21:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/Wj8cXLyIjxKf4R4mbQ1Ojw</id>
    <link href="https://mp.weixin.qq.com/s/Wj8cXLyIjxKf4R4mbQ1Ojw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2709】年度巨制丨「骨与软组织肿瘤药物盘点」SESSION 4：软组织肉瘤的化疗</title>
    <updated>2021-01-16T19:56:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/-tpI9vPQ031piw9jWncZ2A</id>
    <link href="https://mp.weixin.qq.com/s/-tpI9vPQ031piw9jWncZ2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2021 ASCO-GI】安罗替尼8项研究闪亮登场，消化道肿瘤全线开疆拓土</title>
    <updated>2021-01-16T19:56:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/XU-vEb5wpw4a5JWVzAE4Kw</id>
    <link href="https://mp.weixin.qq.com/s/XU-vEb5wpw4a5JWVzAE4Kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 IASLC WCLC即将召开，中国专场亮点抢先看！</title>
    <updated>2021-01-16T19:56:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/-c77XYMZhHUvK73Vdkksqg</id>
    <link href="https://mp.weixin.qq.com/s/-c77XYMZhHUvK73Vdkksqg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>精准治疗，深入探索，单药PARP抑制剂谁最佳？张毅/齐晓伟教授团队发表最新结果</title>
    <updated>2021-01-16T19:56:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/EPYFreAXW-0P_s-mIzmc3Q</id>
    <link href="https://mp.weixin.qq.com/s/EPYFreAXW-0P_s-mIzmc3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离就是战斗，有问必有所得” | 【4】时间掌握好，疗效有保障！</title>
    <updated>2021-01-16T19:56:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/VLVxP3OxuSpu0bL-_wpU9Q</id>
    <link href="https://mp.weixin.qq.com/s/VLVxP3OxuSpu0bL-_wpU9Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MET异常是ALK阳性肺癌中不可忽视的耐药机制（上）</title>
    <updated>2021-01-16T19:56:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/yOnEE0Y7-G_UFk7IAA_bug</id>
    <link href="https://mp.weixin.qq.com/s/yOnEE0Y7-G_UFk7IAA_bug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NSCLC中获得性MET扩增与EGFR-TKI治疗高度相关（上）</title>
    <updated>2021-01-16T19:56:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/c1d60nzQ67FO7Get10thCQ</id>
    <link href="https://mp.weixin.qq.com/s/c1d60nzQ67FO7Get10thCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅 | 神刊CA公布2021年癌症统计数据，癌症死亡率整体下降31%</title>
    <updated>2021-01-16T19:56:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/pU1GHL6WfUhapxlN_OG5_w</id>
    <link href="https://mp.weixin.qq.com/s/pU1GHL6WfUhapxlN_OG5_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2708】领袖汇聚丨中国肿瘤医药营销趋势论坛于今日圆满落幕！</title>
    <updated>2021-01-15T19:39:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/1v0fqLdEI6K6bi8HpyKi2Q</id>
    <link href="https://mp.weixin.qq.com/s/1v0fqLdEI6K6bi8HpyKi2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肝癌规范在行动，未来已来，创新疗法带来新突破</title>
    <updated>2021-01-15T19:39:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/TJ90HEfZAHE8X4HeAnuWIg</id>
    <link href="https://mp.weixin.qq.com/s/TJ90HEfZAHE8X4HeAnuWIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【Best of SABCS】The Year in Review——晚期乳腺癌治疗深度研讨</title>
    <updated>2021-01-15T19:39:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/CS9rb0r4liF7rdfnhg-9Yw</id>
    <link href="https://mp.weixin.qq.com/s/CS9rb0r4liF7rdfnhg-9Yw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【勃学万象·文献精萃】阿法替尼一线治疗中国EGFR突变阳性非小细胞肺癌患者：临床数据综述</title>
    <updated>2021-01-15T19:39:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/ZgGiYAe4ShxyZt7UmS5PZQ</id>
    <link href="https://mp.weixin.qq.com/s/ZgGiYAe4ShxyZt7UmS5PZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【用“实例”说话】局部联合靶向治疗进展期肝癌，患者生存获益逾10年</title>
    <updated>2021-01-15T19:39:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/7yc_4PQ6JB77G_-B8L8ZTQ</id>
    <link href="https://mp.weixin.qq.com/s/7yc_4PQ6JB77G_-B8L8ZTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>